Form 4: Merck & Co. Director Kathy J. Warden Reports Transaction

Director Kathy J. Warden reports a transaction involving Merck & Co. common stock and phantom stock units.

Summary

• On May 31, 2024, Kathy J. Warden, a director of Merck & Co., reported a transaction.
• The transaction involved the disposition of 500 shares of common stock.
• Warden also acquired 1,752.4295 units of phantom stock, which will be settled in cash upon termination of service.
• The price of the phantom stock was $125.54 per unit.
• Following the reported transactions, Warden beneficially owns 12,252.4969 shares of common stock, including shares acquired through dividend reinvestment transactions.

Sentiment

Score: 5

Explanation: This is a routine disclosure of a director's transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

The phantom stock units will be settled in cash upon the reporting person's termination of service, according to a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders (directors, officers, and 10% owners) reporting transactions in their company's securities. These filings are closely watched by investors for insights into management's views on the company's prospects.

Key Dates